(Q28943542)

English

A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese

scientific journal article

In more languages

Statements

scholarly article

1 reference

14 March 2017

A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese (English)

1 reference

14 March 2017

genome-wide association study

0 references

1 reference

based on heuristic

inferred from title

Taisei Mushiroda

2

0 references

David Flockhart

9

object named as

David A. Flockhart

1 reference

14 March 2017

6

object named as

Michiaki Kubo

1 reference

14 March 2017

Yūsuke Nakamura

17

object named as

Yusuke Nakamura

1 reference

14 March 2017

Tatsuhiko Tsunoda

3

object named as

Tatsuhiko Tsunoda

1 reference

14 March 2017

Hitoshi Zembutsu

18

object named as

Hitoshi Zembutsu

1 reference

14 March 2017

5

object named as

Naoya Hosono

1 reference

14 March 2017

Takashi Morizono

4

object named as

Takashi Morizono

1 reference

14 March 2017

16

object named as

Mitsunori Sasa

1 reference

14 March 2017

Kazuma Kiyotani

1

object named as

Kazuma Kiyotani

1 reference

14 March 2017

10

object named as

Fuminori Aki

1 reference

14 March 2017

Yuichi Takatsuka

12

object named as

Yuichi Takatsuka

1 reference

14 March 2017

14

object named as

Shozo Ohsumi

1 reference

14 March 2017

Takashi Yamakawa

15

object named as

Takashi Yamakawa

1 reference

14 March 2017

Yusuke Tanigawara

7

object named as

Yusuke Tanigawara

1 reference

14 March 2017

Chiyo K Imamura

8

object named as

Chiyo K. Imamura

1 reference

14 March 2017

author name string

Koichi Hirata

11

1 reference

14 March 2017

Minoru Okazaki

13

1 reference

14 March 2017

publication date

1 April 2012

1 reference

14 March 2017

Human Molecular Genetics

1 reference

14 March 2017

21

1 reference

14 March 2017

1665–1672

1 reference

14 March 2017

7

1 reference

14 March 2017

describes a project that uses

genome-wide association study

1 reference

based on heuristic

inferred from title

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Ultraconserved Elements in the Human Genome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

The DNA sequence and comparative analysis of human chromosome 10

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Ancient noncoding elements conserved in the human genome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

A high-throughput SNP typing system for genome-wide association studies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

A second generation human haplotype map of over 3.1 million SNPs

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Genomic control for association studies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR597

21 January 2018

Identifiers

10.1093/HMG/DDR597

1 reference

14 March 2017

1 reference

14 March 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28943542&oldid=2009046713"